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Malignant melanoma (MM) represents one of the most
aggressive neoplasms and its frequency is increasing
rapidly. Increased melanoma risk among relatives of
MM patients and familial aggregations of this malig-
nancy point at genetic predisposition as an important
factor of MM pathogenesis. The genetic basis of MM is
complex and appears to involve multiple genes.
CDKN2A is regarded as the major MM susceptibility
gene. In the Polish populati o nc o m m o nC D K N 2 Av a r -
iant (A148T) increases significantly melanoma risk
regardless of the cancer family history. Mutations of
other high risk genes, ARF and CDK4 are extremely
rare and thus clinically insignificant.
The higher rates of CDKN2A/p16 mutations can be
detected only in rare cases characterized by:
1) occurrence of three or more primary melanomas,
2) patients with three or more melanomas in aggre-
gate among first or second degree relatives,
3) families with the presence of three or more cases of
melanoma and/or pancreatic cancer on the same side of
the family. It is thus necessary to perform association
studies focused on identifying genetic markers that
could be used in identifying patients with a high risk of
MM. List of other genes that carry mutations, which are
believed to be associated with moderate MM risk
include XPD, MC1R, BRCA2. Newest genome-wide
association study identified three loci associated with
melanoma risk: 16q24, 11q14-q21, 9p21.
The management with individuals being at increased
MM risk involves clinical screening according to care-
fully planned surveillance schedule and early treat-
ment of MM tumour. The appropriate management
may reduce morbidity and mortality. Genetic testing
and clinical evaluation should be performed, and
family history should be obtained in all patients
affected with MM, also in those with apparently
sporadic tumors.
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